HC
Hemal C Nayak
About Hemal C Nayak
Data last updated:
Hemal C Nayak is a Director at Supreme Pathology Lab Private Limited (since 2021) and Designated Partner at Accufaith Pathology Lab Llp (since 2024). The companies operate in Healthcare. The largest current company by reported revenue is Supreme Pathology Lab Private Limited at ₹56.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 May 2021 | 2021 | ₹56.8 Lakh (FY 2025) | Active | |
| Designated Partner | 14 May 2024 | 2024 | Active |
Board colleagues of Hemal C Nayak
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhavesh Mahendrabhai Thakkar | 07066985 | Supreme Pathology Lab Private Limited | Director |
| Asheshkumar Pravinkumar Shah | 09283616 | Accufaith Pathology Lab Llp | Designated Partner |
| Shital Sureshkumar Shah | 08738961 | Accufaith Pathology Lab Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemal C Nayak
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemal C Nayak
Hemal C Nayak currently holds 2 directorships: Supreme Pathology Lab Private Limited (Director, since 22 May 2021, revenue ₹56.8 Lakh (FY 2025)); Accufaith Pathology Lab Llp (Designated Partner, since 14 May 2024).
Hemal C Nayak was first appointed on 22 May 2021 as Director at Supreme Pathology Lab Private Limited. The most recent appointment on record is 14 May 2024 at Accufaith Pathology Lab Llp.
The current boards of Hemal C Nayak's companies include Bhavesh Mahendrabhai Thakkar (Supreme Pathology Lab Private Limited), Asheshkumar Pravinkumar Shah (Accufaith Pathology Lab Llp), Shital Sureshkumar Shah (Accufaith Pathology Lab Llp).